Results are reported for a small study of 11 patients positive for HIV
and with chronic active viral hepatitis. Low dose zidovudine/interfer
on alfa-2b combined treatment produced a general reduction in alanine
aminotransferase activities and increased the CD4 lymphocyte count, he
patitis B e seroconversion, and the loss of HIV p24 antigen. The treat
ment was well tolerated and progression of HIV disease was not seen.